United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 3 minute read Healthcare Industry News Johnson & Johnson to acquire V-Wave Ltd. in $1.1bn deal to enhance heart failure treatment Johnson & Johnson (NYSE: JNJ) has made headlines with its decision to acquire V-Wave Ltd., a private company… byPallavi MadhirajuAugust 20, 2024